tiprankstipranks
Abera Bioscience AB (DE:8WK)
FRANKFURT:8WK
Germany Market
8WK
Abera Bioscience AB
RESEARCH TOOLSreports

Abera Bioscience AB (8WK) Financial Statements

0 Followers

Abera Bioscience AB Financial Overview

Abera Bioscience AB's market cap is currently €15.58M. The company's EPS TTM is €-0.025; its P/E ratio is -6.59; Abera Bioscience AB is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit----
Operating Income$ -9.18M$ -3.70M$ -2.47M$ -2.63M
EBITDA$ -9.16M$ -3.64M$ -2.47M$ -2.63M
Net Income$ -9.17M$ -3.64M$ -2.47M$ -2.63M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 31.37M$ 2.97M$ 4.89M$ 2.42M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -11.95M$ -902.47K$ -2.65M$ -496.55K
Total Liabilities$ 2.22M$ 2.54M$ 815.92K$ 2.02M
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -9.68M$ -2.75M$ -2.99M$ -2.47M
Operating Cash Flow$ -9.68M$ -2.75M$ -2.99M$ -2.47M
Investing Cash Flow
Financing Cash Flow

Abera Bioscience AB Earnings and Revenue History

Income Statement >

Abera Bioscience AB Debt to Assets

Balance Sheet >

Abera Bioscience AB Cash Flow

Cash Flow >

Abera Bioscience AB Forecast EPS vs Actual EPS

Earnings >